...n, lung and prostate. These four cancers represent half of the overall burden of cancer in Europe, with an economic impact estimated over 125 billion euros. With a potential of global implementation, Trivisio's ARVisS system range will provide more accessible, yet strongly improved, accuracy, completeness and time efficiency in the surgical management of the common, high incidence, malignant cance ...